CORE
🇺🇦Â
 make metadata, not war
Services
Research
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Efficacy and safety of eribulin as first- to third-line treatment in patients with advanced or metastatic breast cancer previously treated with anthracyclines and taxanes
Author
Aogi
Budman
+40Â more
Cardoso
Cortes
Cortes
Cortes
Cortes
De Vos
Dezso
Eisai
Eisenhauer
Ferlay
Hayat
Hiroshi Yano
Inoue
Japan Society of Clinical Oncology
Kaname Kurashita
Kaufman
Kazuo Tamura
Kohjiro Mashino
Kok
Lyman
Majid
McIntyre
MedDRA Japanese Maintenance Organization
Michiyo Saimura
Mototsugu Shimokawa
O'Shaughnessy
O'Shaughnessy
Oken
Reiki Nishimura
Ro
Shigeki Minami
Shigeto Maeda
Shoshu Mitsuyama
Swami
Tan
Twelves
USFDA
Vahdat
van Hasselt
Yuichiro Kai
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref